These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 7533609)

  • 21. Sendai virus-mediated CFTR gene transfer to the airway epithelium.
    Ferrari S; Griesenbach U; Iida A; Farley R; Wright AM; Zhu J; Munkonge FM; Smith SN; You J; Ban H; Inoue M; Chan M; Singh C; Verdon B; Argent BE; Wainwright B; Jeffery PK; Geddes DM; Porteous DJ; Hyde SC; Gray MA; Hasegawa M; Alton EW
    Gene Ther; 2007 Oct; 14(19):1371-9. PubMed ID: 17597790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis.
    Hyde SC; Southern KW; Gileadi U; Fitzjohn EM; Mofford KA; Waddell BE; Gooi HC; Goddard CA; Hannavy K; Smyth SE; Egan JJ; Sorgi FL; Huang L; Cuthbert AW; Evans MJ; Colledge WH; Higgins CF; Webb AK; Gill DR
    Gene Ther; 2000 Jul; 7(13):1156-65. PubMed ID: 10918483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis.
    Gill DR; Southern KW; Mofford KA; Seddon T; Huang L; Sorgi F; Thomson A; MacVinish LJ; Ratcliff R; Bilton D; Lane DJ; Littlewood JM; Webb AK; Middleton PG; Colledge WH; Cuthbert AW; Evans MJ; Higgins CF; Hyde SC
    Gene Ther; 1997 Mar; 4(3):199-209. PubMed ID: 9135733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosis.
    Rich DP; Couture LA; Cardoza LM; Guiggio VM; Armentano D; Espino PC; Hehir K; Welsh MJ; Smith AE; Gregory RJ
    Hum Gene Ther; 1993 Aug; 4(4):461-76. PubMed ID: 7691187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis.
    Knowles MR; Hohneker KW; Zhou Z; Olsen JC; Noah TL; Hu PC; Leigh MW; Engelhardt JF; Edwards LJ; Jones KR
    N Engl J Med; 1995 Sep; 333(13):823-31. PubMed ID: 7544439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Host responses and persistence of vector genome following intrabronchial administration of an E1(-)E3(-) adenovirus gene transfer vector to normal individuals.
    Harvey BG; Hackett NR; Ely S; Crystal RG
    Mol Ther; 2001 Feb; 3(2):206-15. PubMed ID: 11237677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype.
    Mastrangeli A; Harvey BG; Yao J; Wolff G; Kovesdi I; Crystal RG; Falck-Pedersen E
    Hum Gene Ther; 1996 Jan; 7(1):79-87. PubMed ID: 8825871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis.
    Zabner J; Ramsey BW; Meeker DP; Aitken ML; Balfour RP; Gibson RL; Launspach J; Moscicki RA; Richards SM; Standaert TA
    J Clin Invest; 1996 Mar; 97(6):1504-11. PubMed ID: 8617884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Technology evaluation: cystic fibrosis therapy, Genzyme.
    Cockett MI
    Curr Opin Mol Ther; 1999 Apr; 1(2):279-83. PubMed ID: 11715952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the human cystic fibrosis transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene transfer.
    Yoshimura K; Rosenfeld MA; Nakamura H; Scherer EM; Pavirani A; Lecocq JP; Crystal RG
    Nucleic Acids Res; 1992 Jun; 20(12):3233-40. PubMed ID: 1377820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenovirus-mediated in vivo gene transfer.
    Brody SL; Crystal RG
    Ann N Y Acad Sci; 1994 May; 716():90-101; discussion 101-3. PubMed ID: 7517653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prospects of gene therapy in mucoviscidosis using viral infection of the airway epithelium].
    Bayle JY; Boucher RC
    Rev Mal Respir; 1994; 11(4):345-55. PubMed ID: 7526426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy.
    Hyde SC; Gill DR; Higgins CF; Trezise AE; MacVinish LJ; Cuthbert AW; Ratcliff R; Evans MJ; Colledge WH
    Nature; 1993 Mar; 362(6417):250-5. PubMed ID: 7681548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium.
    Zhang L; Button B; Gabriel SE; Burkett S; Yan Y; Skiadopoulos MH; Dang YL; Vogel LN; McKay T; Mengos A; Boucher RC; Collins PL; Pickles RJ
    PLoS Biol; 2009 Jul; 7(7):e1000155. PubMed ID: 19621064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung.
    Crystal RG; Jaffe A; Brody S; Mastrangeli A; McElvaney NG; Rosenfeld M; Chu CS; Danel C; Hay J; Eissa T
    Hum Gene Ther; 1995 May; 6(5):643-66. PubMed ID: 7578401
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of the efficacy and safety of in vitro, adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA.
    Mittereder N; Yei S; Bachurski C; Cuppoletti J; Whitsett JA; Tolstoshev P; Trapnell BC
    Hum Gene Ther; 1994 Jun; 5(6):717-29. PubMed ID: 7948134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis.
    Chu CS; Trapnell BC; Curristin SM; Cutting GR; Crystal RG
    J Clin Invest; 1992 Sep; 90(3):785-90. PubMed ID: 1381723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lentivirus-mediated gene transfer to the respiratory epithelium: a promising approach to gene therapy of cystic fibrosis.
    Copreni E; Penzo M; Carrabino S; Conese M
    Gene Ther; 2004 Oct; 11 Suppl 1():S67-75. PubMed ID: 15454960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correction of the apical membrane chloride permeability defect in polarized cystic fibrosis airway epithelia following retroviral-mediated gene transfer.
    Olsen JC; Johnson LG; Stutts MJ; Sarkadi B; Yankaskas JR; Swanstrom R; Boucher RC
    Hum Gene Ther; 1992 Jun; 3(3):253-66. PubMed ID: 1379473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis.
    Zuckerman JB; Robinson CB; McCoy KS; Shell R; Sferra TJ; Chirmule N; Magosin SA; Propert KJ; Brown-Parr EC; Hughes JV; Tazelaar J; Baker C; Goldman MJ; Wilson JM
    Hum Gene Ther; 1999 Dec; 10(18):2973-85. PubMed ID: 10609658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.